Company Overview and News

 
Enertopia Provides Corporate Update

2018-09-21 globenewswire
KELOWNA, British Columbia, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Enertopia Corporation, (ENRT) on the OTCQB and (TOP) on the CSE (the "Company" or "Enertopia"), is pleased to announce it has closed the final tranche of CAD $66,750 from a Private Placement. Enertopia will be issuing 2,225,000 common shares at CAD$0.03 and 2,225,000 whole warrants that expire on September 21, 2021, with an exercise price of USD $0.
ENRT CYP TOP CYDVF

 
Enertopia Provides Corporate Update

2018-08-31 globenewswire
KELOWNA, British Columbia, Aug. 31, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Enertopia Corporation (ENRT) on the OTCQB and (TOP) on the CSE (the "Company" or "Enertopia") is pleased to announce it has closed the first tranche of CAD $132,000 from a Private Placement. Enertopia will be issuing 4,400,000 common shares at CAD$0.03 and 4,400,000 whole warrants that expire on August 31, 2021, with an exercise price of USD $0.
ENRT TOP

 
Launch of Test Work and Drilling Program

2018-08-13 accesswire
KELOWNA, BC / ACCESSWIRE / August 13, 2018 / Enertopia Corporation (OTCQB: ENRT) on the OTCQB and (CSE: TOP) on the CSE (the "Company" or "Enertopia") is pleased to announce the start of the second phase of bench-scale test work on lithium bearing clays from Clayton Valley, NV. The first phase has established that a synthetic brine high in lithium and low in magnesium can be produced by leaching at an elevated pH.
ENRT IONEXCHANG TOP 500214

 
Innovative Lithium Extraction Technique, Summary of Testing

2018-06-11 accesswire
KELOWNA, BC / ACCESSWIRE / June 11, 2018 / Enertopia Corporation (ENRT) on the OTCQB and (TOP) on the CSE, (OTCQB: ENRT) (CSE: TOP) (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium compounds by our technology partner, Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT IONEXCHANG TOP 500214

 
Second Stage Testing Completed “Assays Pending”

2018-06-04 globenewswire
KELOWNA, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- Enertopia Corporation (OTCQB:ENRT) and (CSE:TOP) (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium by our technology partner Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT NRM NRVTD TOP NRVTF

38
Lithium Investment: Balancing Battery Demand Against Innovative Production And Supply

2018-05-29 seekingalpha
So much so, that many users are jumping in with investment dollars to stimulate and foster growth.
PLS PCRFY PILBF ALB LTUM FTI.WI TYHOF TOP FMC LACDF NMKEF ENRT AVLIF NMX 8015 RHHNF OROCF MLNLF LAC

 
Innovative Lithium Extraction Technique in Final Stage of Testing

2018-05-15 globenewswire
KELOWNA, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Enertopia Corporation (OTC:ENRT) on the OTCQB and (CSE:TOP) on the CSE (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium by our technology partner Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT AA.H CYP TOP AXVEF CYDVF

 
Lithium Brine Bench Testing Update

2018-04-24 globenewswire
KELOWNA, British Columbia, April 24, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Enertopia Corporation (ENRT) on the OTCQB and (TOP) on the CSE (the "Company" or "Enertopia") is pleased to announce the following synthetic lithium brine testing update for the recovery of Lithium by our technology partner Genesis Water Technologies Inc. (GWT), a leader in specialized water treatment solutions.
ENRT TOP

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to CNSX:TOP / Enertopia Corp on message board site Silicon Investor.

Off Topic - Anything Goes Off Topic - Anything Goes Off Topic - Anything Goes Off Topic (Every Day Technology) Off Topic (Every Day Technology) Off Topic (Every Day Technology)
Cisco Systems, Inc. - Off-topic postings Cisco Systems, Inc. - Off-topic postings Cisco Systems, Inc. - Off-topic postings WSEA - off topic and general comments thread WSEA - off topic and general comments thread WSEA - off topic and general comments thread
GameStop Corp (GME) GameStop Corp (GME) GameStop Corp (GME) Stop the War! Stop the War! Stop the War!
Ventas VTR, another u0026#034;PSYCLE smu0026#034; depr. buy, w/stop Ventas VTR, another u0026#034;PSYCLE smu0026#034; depr. buy, w/stop Ventas VTR, another u0026#034;PSYCLE smu0026#034; depr. buy, w/stop Top Image Systems Ltd. (TISA) Top Image Systems Ltd. (TISA) Top Image Systems Ltd. (TISA)
Need help, filing for an injunction to stop a house demoliti Need help, filing for an injunction to stop a house demoliti Need help, filing for an injunction to stop a house demoliti Enertopia Corporation Enertopia Corporation Enertopia Corporation